相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Drug Transporters in Drug Efficacy and Toxicity
M. K. DeGorter et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
Lack of association between ABCC2 gene variants and treatment response in epilepsy
Eva Hilger et al.
PHARMACOGENOMICS (2012)
Common Nonsynonymous Substitutions in SLCO1B1 Predispose to Statin Intolerance in Routinely Treated Individuals With Type 2 Diabetes: A Go-DARTS Study
L. A. Donnelly et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Decreased Hepatic Breast Cancer Resistance Protein Expression and Function in Multidrug Resistance-Associated Protein 2-Deficient (TR-) Rats
Wei Yue et al.
DRUG METABOLISM AND DISPOSITION (2011)
Intestinal Absorption of HMG-CoA Reductase Inhibitor Pitavastatin Mediated by Organic Anion Transporting Polypeptide and P-Glycoprotein/Multidrug Resistance 1
Yoshiyuki Shirasaka et al.
DRUG METABOLISM AND PHARMACOKINETICS (2011)
Differential Effect of Grapefruit Juice on Intestinal Absorption of Statins Due to Inhibition of Organic Anion Transporting Polypeptide and/or P-glycoprotein
Yoshiyuki Shirasaka et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy
Mike Ufer et al.
PHARMACOGENETICS AND GENOMICS (2011)
Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function
S. Laechelt et al.
PHARMACOGENOMICS JOURNAL (2011)
Lack of effect of genetic polymorphisms of SLCO1B1 on the lipid-lowering response to pitavastatin in Chinese patients
Guo-ping Yang et al.
ACTA PHARMACOLOGICA SINICA (2010)
Pitavastatin: A New HMG-CoA Reductase Inhibitor
Terri M. Wensel et al.
ANNALS OF PHARMACOTHERAPY (2010)
OATP1B1 388A>G polymorphism and pharmacokinetics of pitavastatin in Chinese healthy volunteers
J. Wen et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2010)
The 5′-Untranslated Region of Multidrug Resistance Associated Protein 2 (MRP2; ABCC2) Regulates Downstream Open Reading Frame Expression through Translational Regulation
Yuanyuan Zhang et al.
MOLECULAR PHARMACOLOGY (2010)
Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs
Ichiro Ieiri et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Non-response to antiepileptic pharmacotherapy is associated with the ABCC2-24C>T polymorphism in young and adult patients with epilepsy
Mike Ufer et al.
PHARMACOGENETICS AND GENOMICS (2009)
Genetic variations and gene expression of transporters in drug disposition and response
Ying Huang et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
The effect of SLCO1B1*15 on the disposition of pravastatin and pitavastatin is substrate dependent:: the contribution of transporting activity changes by SLCO1B1*15
Jian Wei Deng et al.
PHARMACOGENETICS AND GENOMICS (2008)
Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients
Masatomo Miura et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2007)
SLCO1B1 (OATP1B1, an uptake transporter) and ABCG2 (BCRP, an efflux transporter) variant alleles and pharmacokinetics of pitavastatin in healthy volunteers
I. Ieiri et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
SLCO1B1 521T→C functional genetic polymorphism and lipid-lowering efficacy of multiple-dose pravastatin in Chinese coronary heart disease patients
Wei Zhang et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants
Richard H. Ho et al.
PHARMACOGENETICS AND GENOMICS (2007)
Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer
Ji-Youn Han et al.
CANCER (2007)
MRP2 haplotypes confer differential susceptibility to toxic liver injury
Ji Ha Choi et al.
PHARMACOGENETICS AND GENOMICS (2007)
Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans
Kari T. Kivisto et al.
PHARMACEUTICAL RESEARCH (2007)
High-dose methotrexate in pediatric acute lymphoblastic leukemia:: Impact of ABCC2 polymorphisms on plasma concentrations
Thomas Rau et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics
Mikko Niemi et al.
PHARMACOGENETICS AND GENOMICS (2006)
Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients
Maarten Naesens et al.
TRANSPLANTATION (2006)
G2677T and C3435T genotype and haplotype are associated with hepatic ABCB1 (MDR1) expression
PF Song et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductase
H Fujino et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2005)
Effect of OATPIBI (SLCOIBI) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers
JY Chung et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells
Y Kameyama et al.
PHARMACOGENETICS AND GENOMICS (2005)
Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer
QY Zhou et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Pitavastatin
RYA Mukhtar et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2005)
Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans
M Hirano et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability
LMS Chan et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
The superfamily of organic anion transporting polypeptides
B Hagenbuch et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2003)
Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practice
JP Frolkis et al.
AMERICAN JOURNAL OF MEDICINE (2002)
NK-104: a novel synthetic HMG-CoA reductase inhibitor
K Kajinami et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2000)
分享论文
